Gilead Sciences Financial Statements
Gilead Sciences Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
Gilead Sciences Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 4,230.0 | 3,026.1 | 2,028.4 |
| Gross Profit ($ mil.) | 3,461.3 | 2,592.8 | 1,768.1 |
| Operating Income ($ mil.) | 2,164.5 | (758.8) | 1,111.1 |
| Total Net Income ($ mil.) | 1,615.3 | (1,190.0) | 813.9 |
| Diluted EPS (Net Income) | 1.68 | (1.29) | 0.86 |
Gilead Sciences Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 1,278.1 | 1,258.2 | 1,094.7 |
| Gross Profit ($ mil.) | 1,012.4 | 1,018.3 | 879.2 |
| Operating Income ($ mil.) | 605.5 | 668.0 | 514.5 |
| Total Net Income ($ mil.) | 442.8 | 496.1 | 401.6 |
| Diluted EPS (Net Income) | 0.46 | 0.51 | 0.42 |
Gilead Sciences Stock Quote & Chart
| 11/21/08 16:00:04 EST •
NASDAQ •
41.46
•
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Gilead Sciences Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 9.11 | 3.19 | 1.45 |
| Price/Earnings Ratio | 24.84 | 14.45 | 15.11 |
| Price/Book Ratio | 11.33 | 2.53 | 1.41 |
| Price/Cash Flow Ratio | 24.19 | 12.17 | 9.14 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Gilead Sciences Financial Ratios
Gilead Sciences Competitive Intelligence
| Bristol-Myers Squibb | GlaxoSmithKline | Roche | |
|---|---|---|---|
| Annual Sales ($ mil.) | 19,348.0 | 22,716.0 | 34,465.2 |
| Employees | 42,000 | 103,401 | 74,372 |
| Market Cap ($ mil.) | 39,993.2 | -- | -- |
Competitive Landscape





